Immunocore Holdings's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Immunocore Holdings is scheduled to report earnings on May 8, 2024, and the estimated EPS forecast is $-0.36. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21
Income Statement	-
Total Revenue	£ 48.06M	£ 41.20M	£ 32.00M	£ 22.47M	£ 6.59M
Gross Profit	£ 47.95M	£ 41.14M	£ 31.97M	£ 22.23M	-
EBIT	£ -21.29M	£ 6.77M	£ -6.88M	£ -16.45M	£ -37.83M
EBITDA	£ -19.95M	£ 8.25M	£ -5.24M	£ -14.77M	£ -36.11M
Net Income Common Stockholders	£ -25.20M	£ 6.23M	£ -6.12M	£ -16.13M	£ -39.39M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	£ 332.54M	£ 347.19M	£ 208.06M	£ 205.85M	£ 237.89M
Total Assets	£ 435.52M	£ 444.67M	£ 295.57M	£ 282.04M	£ 301.77M
Total Debt	£ 69.30M	£ 74.08M	£ 67.69M	£ 64.71M	£ 63.84M
Net Debt	£ -263.24M	£ -273.11M	£ -140.37M	£ -141.15M	£ -174.05M
Total Liabilities	£ 156.76M	£ 149.85M	£ 130.92M	£ 118.74M	£ 130.23M
Stockholders Equity	£ 278.76M	£ 294.82M	£ 164.65M	£ 163.30M	£ 171.55M
Cash Flow	-
Free Cash Flow	£ 4.70M	£ 7.70M	£ -9.52M	£ -30.97M	£ -16.61M
Operating Cash Flow	£ 6.03M	£ 8.09M	£ -9.18M	£ -30.83M	£ -16.33M
Investing Cash Flow	£ 332.00K	£ 203.00K	£ -209.00K	£ -133.00K	£ -265.00K
Financing Cash Flow	£ -1.19M	£ 117.52M	£ -538.00K	£ -1.33M	£ -2.06M

Currency in GBP

Immunocore Holdings Earnings and Revenue History

Income Statement >

Immunocore Holdings Debt to Assets

Balance Sheet >

Immunocore Holdings Cash Flow

Cash Flow >

Immunocore Holdings Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing